Tiziana Life Sciences plc – Interim Results for the Six Months Ended 30 June 2021

NEXT STORY
National Headache Foundation Launches Primary Care Migraine Program
PREV STORY
Elevations RTC Creates a Safe Place For Struggling Teens
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma to Host Fourth Quarter and Full-Year 2016 Financial Results Conference Call on February 23, 2017

TEL-AVIV, Israel, Feb. 16, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” ...

author_avatar
NASDAQ Market News

Novelion Therapeutics Reports Third Quarter 2017 Financial Results and Announces Leadership Change

Company Reiterates FY 2017 Guidance for Total Net Revenues of $135-$145 millionCompany Announces Leadership ...

author_avatar
NASDAQ Market News

Cara Therapeutics Appoints Christopher A. Posner to Board of Directors

STAMFORD, Conn., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical ...

author_avatar
NASDAQ Market News